from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2007c/fdxA

LFCtreatmentdescriptionclass of inhibitor

0.498

Amikacinug/mL Amikacintranslation

0.597

Cap5-10ug/mL Capreomycintranslation

0.454

Rox10-50 ug/mL Roxithromycintranslation

0.090

SM2-5 ug/mL Streptomycintranslation

0.372

Tet5-10 ug/mL Tetracyclinetranslation

0.053

Rif0.2-5ug/mL Rifampicintranscription

0.259

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.688

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.050

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.412

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.535

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.300

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.562

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.147

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.247

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.311

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.095

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.401

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.220

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.016

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.159

KCN5-20 ug/mL Potassium cyaniderespiration

-0.305

NaN30.2-2 mM Sodium aziderespiration

-0.668

Nigericin50 uM Nigericinrespiration

-0.494

TRC10-150 ug/mL Triclosanrespiration

0.023

TRZ10-25 ug/mL Thioridazinerespiration

1.017

Valinomycin0.5-10 uM Valinomycinrespiration

-0.212

ZnSO42 mM ZnSO4respiration

0.242

menadione6-10 ug/mL Menadionerespiration

-0.607

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.400

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.333

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.625

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

4.127

NRP_1Non-replicating persistence stage 1dosRassociated

-0.571

Amp0.2mg/mL AmpicillincellWall

-0.098

Cephalexin20-100 ug/mL CephalexincellWall

-0.456

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.010

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.443

EMB10-20 ug/mL EthambutolcellWall

-0.300

Eta12-40 ug/mL EthionamidecellWall

-0.297

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.129

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.241

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.459

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.027

BZA0.12 mg/mL BenzamidearomaticAmides

-0.804

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.730

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.640

H2O24 mM hydrogen peroxideDNAdamaging

-0.012

Levo10 ug/mL LevofloxacinDNAdamaging

-0.538

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.549

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.035

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.279

UVUV-irradiationDNAdamaging

0.070

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.216

Antimycin12.5-50 ug/mL Antimycin A?

0.015

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.029

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.118

PA8240.2-2 ug/mL PA-824?

2.667

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.216

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.970

Verapamil50 uM Verapamil?

-0.179

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.629

methoxatin10-20 ug/mL Methoxatin?